ProShares S&P 500 Dividend Aristocrats ETF's (NOBL) dividend strategy may no longer be effective. Explore six superior ...

A long-running confirmatory trial of two of Sarepta Therapeutics’ Duchenne muscular dystrophy drugs has missed its main goal.

Shares fall 1.4pc; Advent’s Anjarwala picks Heidelberg Materials; Antipodes Ross favours Brookdale Senior Living; Marathon ...

Still, SEIV is the only one to outperform SPYV over the last three years, and the key reason could be that it's also the only ...

Stocks pared declines after Democrats laid down conditions for a deal to end the government shutdown, a proposal that ...

Small caps continued to shine in October, with the ASX Small Ordinaries rising 2%, achieving a 25% YTD gain and significantly ...

BPS noted that the increase in exports was mainly driven by a 9.57 percent rise in non-oil and gas exports y-o-y.

Key Points Sold 111,305 shares of ONEQ, an estimated $8.92 million trade based on quarterly average pricing Transaction represented 3.6% of 13F reportable assets under management Post-trade stake: 0 ...

Aaron Rodgers was looking to become the fifth QB to beat all 32 teams, when he faced the Packers on "Sunday Night Football." Green Bay spoiled that.

Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...

At the 2022 and 2025 elections, the Coalition campaigned on a policy of net zero emissions by 2050. The Liberals were in the process of developing a new policy, but when the National Party ditched net ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...